adenocarcinoma
Showing NaN - NaN of 10
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
-
Tucson, Arizona
- +34 more
Oct 11, 2021
Adenocarcinoma, NSCLC Trial in Boston (Erlotinib)
Completed
- Adenocarcinoma
- Non-small Cell Lung Cancer
-
Boston, Massachusetts
- +2 more
Dec 7, 2019
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Adenocarcinoma Trial in United States (Epirubicin with Cyclophosphamide, followed by a Taxane, Epirubicin with a Taxane)
Completed
- Adenocarcinoma
- Epirubicin with Cyclophosphamide, followed by a Taxane
- Epirubicin with a Taxane
-
Mobile, Alabama
- +53 more
May 24, 2011
Pancreatic Cancer, Adenocarcinoma Trial in United States (ARQ 501 in combination with gemcitabine)
Completed
- Pancreatic Cancer
- Adenocarcinoma
- ARQ 501 in combination with gemcitabine
-
Mobile, Alabama
- +14 more
Apr 28, 2009
Esophageal Tumors, Stomach Tumors, Adenocarcinoma Trial in United States (tezacitabine, 5-fluorouracil)
Completed
- Esophageal Neoplasms
- +2 more
-
Birmingham, Alabama
- +28 more
Jul 10, 2006